Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oligog cf-5/20 (1 trial)
diclofenac (voltaren) (2 trials)
Cystic Fibrosis (Phase 2)
Fibrosis (Phase 2)
Trials (3 total)
Trial APIs (2 total)